BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34638566)

  • 1. A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells.
    Bosch NC; Martin LM; Voskens CJ; Berking C; Seliger B; Schuler G; Schaft N; Dörrie J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
    Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
    Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation.
    Mortier E; Woo T; Advincula R; Gozalo S; Ma A
    J Exp Med; 2008 May; 205(5):1213-25. PubMed ID: 18458113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.
    Elpek KG; Rubinstein MP; Bellemare-Pelletier A; Goldrath AW; Turley SJ
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21647-52. PubMed ID: 21098276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunity.
    Karimi K; Karimi Y; Chan J; Boudreau JE; Basset J; Chew MV; Reid S; Bramson JL; Wan Y; Ashkar AA
    Innate Immun; 2015 Aug; 21(6):626-34. PubMed ID: 25749844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner.
    Anguille S; Van Acker HH; Van den Bergh J; Willemen Y; Goossens H; Van Tendeloo VF; Smits EL; Berneman ZN; Lion E
    PLoS One; 2015; 10(5):e0123340. PubMed ID: 25951230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection.
    Jinushi M; Takehara T; Tatsumi T; Kanto T; Groh V; Spies T; Suzuki T; Miyagi T; Hayashi N
    J Immunol; 2003 Nov; 171(10):5423-9. PubMed ID: 14607946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells.
    Koka R; Burkett P; Chien M; Chai S; Boone DL; Ma A
    J Immunol; 2004 Sep; 173(6):3594-8. PubMed ID: 15356102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells.
    Münz C; Dao T; Ferlazzo G; de Cos MA; Goodman K; Young JW
    Blood; 2005 Jan; 105(1):266-73. PubMed ID: 15331446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-15 and its receptor augment dendritic cell vaccination against the neu oncogene through the induction of antibodies partially independent of CD4 help.
    Steel JC; Ramlogan CA; Yu P; Sakai Y; Forni G; Waldmann TA; Morris JC
    Cancer Res; 2010 Feb; 70(3):1072-81. PubMed ID: 20086176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
    Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
    J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives.
    Xu H; Shi M; Shao C; Li H; Wu J; Yu Y; Fang F; Guo Y; Xiao W
    Microb Cell Fact; 2021 Jun; 20(1):115. PubMed ID: 34107983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
    Wu Z; Xu Y
    J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Body Composition and Immunity: Visceral Adipose Tissue Produces IL-15 and Muscle Strength Inversely Correlates with NK Cell Function in Elderly Humans.
    Al-Attar A; Presnell SR; Clasey JL; Long DE; Walton RG; Sexton M; Starr ME; Kern PA; Peterson CA; Lutz CT
    Front Immunol; 2018; 9():440. PubMed ID: 29559978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15.
    Vujanovic L; Szymkowski DE; Alber S; Watkins SC; Vujanovic NL; Butterfield LH
    Blood; 2010 Jul; 116(4):575-83. PubMed ID: 20430958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cell survival mediated through the regulatory synapse with human DCs requires IL-15Ralpha.
    Brilot F; Strowig T; Roberts SM; Arrey F; Münz C
    J Clin Invest; 2007 Nov; 117(11):3316-29. PubMed ID: 17948125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.
    Anguille S; Lion E; Tel J; de Vries IJ; Couderé K; Fromm PD; Van Tendeloo VF; Smits EL; Berneman ZN
    PLoS One; 2012; 7(12):e51851. PubMed ID: 23284789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine complex-expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells.
    Jungraithmayr W; Codarri L; Bouchaud G; Krieg C; Boyman O; Gyülvészi G; Becher B; Weder W; Münz C
    Am J Respir Crit Care Med; 2013 Jun; 187(12):1349-59. PubMed ID: 23590269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells.
    Boudreau JE; Stephenson KB; Wang F; Ashkar AA; Mossman KL; Lenz LL; Rosenthal KL; Bramson JL; Lichty BD; Wan Y
    Cancer Res; 2011 Apr; 71(7):2497-506. PubMed ID: 21307131
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Anton OM; Peterson ME; Hollander MJ; Dorward DW; Arora G; Traba J; Rajagopalan S; Snapp EL; Garcia KC; Waldmann TA; Long EO
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):522-531. PubMed ID: 31871169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.